Business Description
T2 Biosystems Inc
NAICS : 325413
SIC : 2835
ISIN : US89853L3024
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | -1.53 | |||||
Debt-to-Equity | -1.31 | |||||
Debt-to-EBITDA | -1.24 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -40.6 | |||||
Beneish M-Score | -2.66 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -84.6 | |||||
3-Year EBITDA Growth Rate | 78 | |||||
3-Year EPS without NRI Growth Rate | 78.2 | |||||
3-Year FCF Growth Rate | 78.4 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.17 | |||||
9-Day RSI | 9.04 | |||||
14-Day RSI | 7.59 | |||||
12-1 Month Momentum % | 2.51 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.28 | |||||
Quick Ratio | 0.19 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 108.04 | |||||
Days Sales Outstanding | 69.37 | |||||
Days Payable | 46.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.9 | |||||
Shareholder Yield % | -110.8 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -116.97 | |||||
Operating Margin % | -641.95 | |||||
Net Margin % | -636.09 | |||||
FCF Margin % | -654.28 | |||||
ROA % | -132.16 | |||||
ROIC % | -90.66 | |||||
ROC (Joel Greenblatt) % | -380.83 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.03 | |||||
EV-to-EBIT | -1.86 | |||||
EV-to-Forward-EBIT | -1.57 | |||||
EV-to-EBITDA | -1.9 | |||||
EV-to-Revenue | 10.56 | |||||
EV-to-Forward-Revenue | 7.22 | |||||
EV-to-FCF | -1.61 | |||||
Price-to-Median-PS-Value | 0.09 | |||||
Earnings Yield (Greenblatt) % | -53.76 | |||||
FCF Yield % | -144.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
T2 Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 7.176 | ||
EPS (TTM) ($) | -16.658 | ||
Beta | -0.64 | ||
Volatility % | 234.52 | ||
14-Day RSI | 7.59 | ||
14-Day ATR ($) | 1.14931 | ||
20-Day SMA ($) | 15.976789 | ||
12-1 Month Momentum % | 2.51 | ||
52-Week Range ($) | 2.82 - 70 | ||
Shares Outstanding (Mil) | 8.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
T2 Biosystems Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
T2 Biosystems Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
T2 Biosystems Inc Frequently Asked Questions
What is T2 Biosystems Inc(LTS:0A57)'s stock price today?
When is next earnings date of T2 Biosystems Inc(LTS:0A57)?
Does T2 Biosystems Inc(LTS:0A57) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |